메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Aoki Kotaro (Department of Microbiology and Infectious Diseases Toho University School of Medicine Tokyo Japan) Takai Kunitomo (Research and Development Abbott Japan LLC Chiba Japan) Nagasawa Tatsuya (Department of Microbiology and Infectious Diseases Toho University School of Medicine Tokyo Japan) Kashiwagi Katsuhito (General Medicine and Emergency Center (Internal Medicine) Toho University Omori Medical Center Toky) Mori Nobuaki (Department of General Internal Medicine and Infectious Diseases National Hospital Organization Toky) Matsubayashi Keiji (Central Blood Institute Blood Service Headquarters Japanese Red Cross Society Tokyo Japan) Satake Masahiro (Central Blood Institute Blood Service Headquarters Japanese Red Cross Society Tokyo Japan) Tanaka Ippei (Research and Development Abbott Japan LLC Chiba Japan) Kodama Nanae (Department of Clinical Laboratory Toho University Omori Medical Center Tokyo Japan) Shimodaira Takahiro (Department of Clinical Laboratory Toho University Omori Medical Center Tokyo Japan) Ishii Yoshikazu (Department of Microbiology and Infectious Diseases Toho University School of Medicine Tokyo Japan) Miyazaki Taito (General Medicine and Emergency Center (Internal Medicine) Toho University Omori Medical Center Toky) Ishii Toshiaki (Department of Clinical Laboratory Toho University Omori Medical Center Tokyo Japan) Morita Toshisuke (Department of Laboratory Medicine Toho University School of Medicine Tokyo Japan) Yoshimura Toru (Research and Development Abbott Japan LLC Chiba Japan) Tateda Kazuhiro (Department of Microbiology and Infectious Diseases Toho University School of Medicine Tokyo Japan)
저널정보
대한진단검사의학회 Annals of Laboratory Medicine Annals of Laboratory Medicine 제41권 제6호
발행연도
2021.11
수록면
568 - 576 (9page)
DOI
10.3343/alm.2021.41.6.568

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is generally diagnosed by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (approximately 80%). We evaluated the performance of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the combination of RT-PCR and the IgG assay for COVID-19 diagnosis. Methods: In this retrospective study, 206 samples from 70 COVID-19 cases at two hospitals in Tokyo that were positive using RT-PCR were used to analyze the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Red Cross Society (N=100) samples were used to evaluate specificity. Results: Sensitivity increased daily after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case groups. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 cases with multiple samples and from another case with a positive result in the IgG assay for the first available sample. Conclusions: The combination of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the limitations of each method.

목차

등록된 정보가 없습니다.

참고문헌 (19)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0